Company News: Curetis To Attend Key Conferences in the Fourth Quarter of 2019

Curetis N.V. (the “Company” and, together with its subsidiaries, “Curetis”), a developer of next-level molecular diagnostic solutions, today announced that the Curetis Group Companies will be attending several key conferences in the fourth quarter of 2019.

November 2019

EIT Health German-French Bilateral Meeting, November 4-5 2019 – Mannheim, Germany (Ares Genetics GmbH)

54th Annual Northeast Branch American Society for Microbiology, November 7-8, 2019 – Randolph, MA, USA (Curetis USA Inc.)

DICON/DASON Fall 2019 Symposium (Duke Infection Control Outreach Network / Duke Antimicrobial Stewardship Outreach Network), November 8, 2019 – Raleigh, NC, USA (Curetis USA Inc.)

Southeastern Association of Clinical Microbiology (SEACM) Annual Fall Meeting, November 14-16, 2019 – Myrtle Beach, SC, USA (Curetis USA Inc.)

DxPx – Diagnostics and Research Tools Partnering Conference, November 18, 2019 – Düsseldorf, Germany (Ares Genetics & Curetis GmbH)

European Summit of Industrial Biotechnology, November 18-20, 2019 – Graz, Austria (Ares Genetics GmbH)

Emerging Antimicrobials and Diagnostics in AMR 2019, November 19-20, 2019 – Amsterdam, The Netherlands (Ares Genetics GmbH & Curetis GmbH)

EPAASM 49th Annual Symposium (Eastern Pennsylvania Branch of the American Society for Microbiology), November 22, 2019 – Philadelphia, PA, USA (Curetis USA Inc.)

December 2019

3rd Congress Immunotherapies & Innovations for Infectious Diseases, December 3-4, 2019 – Lyon, France (Ares Genetics GmbH)

ASPH Midyear Clinical Meeting (American Society of Health-System Pharmacists), December 8-12, 2019 – Las Vegas, NV, USA – (Curetis USA Inc., booth #773)

 13. Nationaler Qualitätskongress Gesundheit, December 12-13, 2019 – Berlin, Germany (Ares Genetics GmbH)